preheader BJH 1

header website

Welcome to the 23rd EHA congress in Stockholm, Sweden!

As the premier hematology congress in Europe EHA is going to offer you a congress program covering every subspecialty in hematology and the opportunity to network with experts from all over the globe.

The educational and scientific program will highlight state-of-the-art clinical practice, the latest findings in hematology research and many more interesting sessions. The congress also provides you with the opportunity to attend satellite programs, Updates-in-Hematology and to visit the exhibition organised by pharmaceutical companies.

Congress objectives

The EHA annual congress provides a forum for presenting original unpublished data and sharing ideas for hematological innovation as well as disseminating evidence-based knowledge of primary clinical relevance.

Hematologists and affiliated professionals attending the EHA congress will be able to:

  • Enhance their knowledge of evidence-based approaches on diagnosis and treatment for hematologic diseases.
  • Access the latest results on clinical and translational research in hematologic disorders.
  • Be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties.
  • Communicate, collaborate and network with representatives of a large international audience – medical professionals, national hematology societies, patient groups, medical industry and the media.

Tom Feys, MSc

tom

Medical writer

Back to Top